Corrigendum to "Neuropathy in adolescents with type 1 diabetes: Confirmatory diagnostic tests, bedside tests, and risk factors” [Diab. Res. Clin. Pract. 201 (2023) 110736]

TY - GEN

T1 - Corrigendum to "Neuropathy in adolescents with type 1 diabetes

T2 - Confirmatory diagnostic tests, bedside tests, and risk factors” [Diab. Res. Clin. Pract. 201 (2023) 110736]

AU - Rasmussen, Vinni Faber

AU - Thrysøe, Mathilde

AU - Randel Nyengaard, Jens

AU - Tankisi, Hatice

AU - Karlsson, Páll

AU - Hansen, John

AU - Krogh, Klaus

AU - Brock, Christina

AU - Kamperis, Konstantinos

AU - Madsen, Mette

AU - Singer, Wolfgang

AU - Vestergaard, Esben Thyssen

AU - Kristensen, Kurt

AU - Terkelsen, Astrid Juhl

PY - 2023/11

Y1 - 2023/11

N2 - The authors regret some counting and typographical errors in Table 3. There have been errors in the extraction of some of the count data for the 2 × 2 tables, where a few numbers have been based on previous results due to a missing reading of a code in R. These errors were present in only a few of the results, and they do not alter the main findings of that higher insulin dose per kilogram per day, previous smoking, and higher triglyceride levels were found to increase the relative risk for neuropathy. Remarkably, the relative risk ratio and confidence intervals should be interpreted cautiously due to the small population in the study. All statistical calculations in the article are rechecked and verified by a statistician. The corrected Table 3 is shown below. The authors would like to apologize for any inconvenience caused.

AB - The authors regret some counting and typographical errors in Table 3. There have been errors in the extraction of some of the count data for the 2 × 2 tables, where a few numbers have been based on previous results due to a missing reading of a code in R. These errors were present in only a few of the results, and they do not alter the main findings of that higher insulin dose per kilogram per day, previous smoking, and higher triglyceride levels were found to increase the relative risk for neuropathy. Remarkably, the relative risk ratio and confidence intervals should be interpreted cautiously due to the small population in the study. All statistical calculations in the article are rechecked and verified by a statistician. The corrected Table 3 is shown below. The authors would like to apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85174155246&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2023.110950

DO - 10.1016/j.diabres.2023.110950

M3 - Corrigendum

C2 - 37852855

SN - 0168-8227

VL - 205

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

M1 - 110950

ER -